Skip to content
Review

Kontinuierliche Glukosemessung und automatisierte Insulindosierungssysteme im klinischen Alltag

Aug 2026 · Die Innere Medizin · Vol 67, pp. 1063 - 1072 · 0 citations · 20 references
Medicine

TL;DR

A practice-oriented evaluation of the indications, clinical benefits, and safety of modern diabetes technologies and suggests that technologies should be offered according to individual needs, abilities, preferences, and life circumstances and implemented early, including at the time of diagnosis.

View source

Similar papers

Review Aug 2026

Early Consideration of Automated Insulin Delivery in Type 2 Diabetes: A Critical Review.

Randomized and real-world studies demonstrate that AID systems significantly improve A1C and time in range while minimizing hypoglycemia, without increasing treatment complexity or patient burden, and position AID as a practical and effective strategy to overcome long-standing therapeutic inertia in type 2 diabetes.

Z. Tariq, Grazia Aleppo, Anders L. Carlson et al. · 0 citations
Open access Aug 2026

Real-World Outcomes of Automated Insulin Delivery Use in Hospitalized Adults With Diabetes.

Continuation of insulin pumps was associated with improvement in hyperglycemia without increased hypoglycemia risk and with shorter LOS in the hospital and standardized institutional policies may help expand safe continuation of AID during hospitalizations.

Kathleen R Ruddiman, J. Evans, Joseph A. Aloi et al. · 0 citations
Aug 2026

Continuous Glucose Monitoring and Automated Insulin Delivery in Infants with Type 1 Diabetes: Real-World Evidence to Support Future International Guidelines.

CGM is safe in very young children, with AID systems proving superior to traditional therapy, and real-world evidence supports incorporating AID consideration into future international guidelines from the time of pediatric diagnosis.

M. Marigliano, A. Scaramuzza, C. Arnaldi et al. · 0 citations
Open access Aug 2026

Continuous Glucose Monitoring-Informed Basal Insulin Optimization System in Adults with Type 2 Diabetes: Initial Evaluation of Efficacy, Safety, and Impact on Patient-Reported Outcomes

CGM-informed basal insulin optimization with a prototype of Dexcom Smart Basal was associated with improvements in glycemic control and treatment satisfaction in adults with T2D, with a favorable safety profile, and the system may help overcome clinical inertia and support individualized insulin titration in real-world...

S. Oser, C. Crystal, K. Hames et al. · 0 citations
Open access Jul 2026

Precision Insulin-Pump Calibration and Optimal Insulin Delivery to Improve Blood Glucose Levels

A simple, automated, and individualized insulin-pump calibration system based on a series of measures taken before and a few hours after carbohydrate ingestion, which modulate the shape of pre-meal insulin dosing to explicitly reduce postprandial BG levels while minimizing the likelihood of dangerously low BG.

I. Aganj, N. Bryant, Leah Morgan Panaro et al. · 0 citations
Review Open access Aug 2026

Continuous glucose monitoring (CGM) systems in Poland, Europe, and beyond in 2025: principles, available technologies, and future perspectives

The most common CGM devices are presented, along with a cost-effectiveness analysis and a critical assessment, and future perspectives are discussed, including AI technologies and modern solutions to enhance user comfort.

Oskar Kublin, D. Filipowicz, Mariusz Stępień · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.